Skip to main content

Tallysomycin, A Third Generation Bleomycin Analog

  • Conference paper

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 76))

Abstract

The bleomycins, discovered in 1966 by Umezawa and colleagues [12], have been the focus of intense interest for a number of years. Unique molecular pharmacologic, clinical pharmacologic, and toxicologic characteristics, and substantial clinical activities have resulted in significant analog development efforts. At present more than 300 analogs of bleomycin have been reported, and these analogs can be divided into three generations. First generation analogs can be thought of as the initial 13 bleomycins isolated. Second generation analogs are those that differ from the initial bleomycins only by changes in the terminal amine structure, or by very minor modifications in the bleomycinic acid portion of the molecule. Third generation analogs can be thought of as those differing significantly from the bleomycins in the bleomycinic acid portion of the molecule. The tallysomycins are third generation bleomycin analogs.

The authors thank Ms. Julie Durantini for excellent typographical assistance, and Dr. Harris Busch for his continuing guidance and support

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bradner WT (1978) BU-2231, A third-generation bleomycin: Preclinical studies. In: Carter SK, Crooke ST, Umezawa H (eds) Bleomycin: current status and new developments. Academic Press, New York, pp 333–342

    Google Scholar 

  2. Broughton A, Strong JE, Crooke ST, Prestayko AW (to be published) A radioimmunoassay for tallysomycin. Cancer Treat Rep

    Google Scholar 

  3. Greenaway FT, Dabrowiak JC, van Husen M, Grulich R, Crooke ST (1978) The transition metal binding properties of a 3rd generation bleomycin analogue, tallysomycin. Biochem Biophys Res Commun 85:1407–1414

    Article  PubMed  CAS  Google Scholar 

  4. Huang CH, Galvan L, Crooke ST (to be published) Quenching of flourescence of bleomycin by ferrour ion and its correlation with DNA-breakage activity. J Biochem

    Google Scholar 

  5. Imanishi H, Ohbayashi M, Nishiyama Y, Kawaguchi H (1978) Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B. Antibiot (Tokyo) 31:667–674

    Article  CAS  Google Scholar 

  6. Kawaguchi H, Tsukiura H, Tomita K, Konishi M, Saito K, Kobaru S, Numata K, Fujisawa K, Miyaki T, Hatori M, Koshiyama H (1977) Tallysomycin, a new antitumor antibiotic complex related to bleomycin. I. Production, isolation and properties. J Antibiot (Tokyo) 30:779–788

    Article  CAS  Google Scholar 

  7. Konishi M, Saito K, Numata K, Tsuno T, Asama K, Tsukiura H, Takayuki N, Kawaguchi H (1977) Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycin A and B. J Antibiot (Tokyo) 30:789–805

    Article  CAS  Google Scholar 

  8. Sikic BI, Mimnaugh EG, Gram TE (1978) Development of quantifiable parameters of bleomycin toxicity in the mouse lung. In: Carter SK, Crooke ST, Umezawa H (eds) Bleomycin: current status and new developments. Academic Press, New York, pp 293–297

    Google Scholar 

  9. Strong JE, Crooke ST (1978) Mechanism of action of tallysomycin, a third generation bleomycin. In: Carter SK, Crooke ST, Umezawa H (eds) Bleomycin: current status and new developments. Academic Press, New York, pp 343–355

    Google Scholar 

  10. Strong JE, Crooke ST (1978) DNA breakage of tallysomycin. Cancer Res 38:3322–3326

    PubMed  CAS  Google Scholar 

  11. Strong JE, Schurig J, Issell BF, Tavel A, Florczyk AP, Crooke ST (to be published) Pharmacokinetics of tallysomycin and bleomycin in the beagle dog. Cancer Treat Rep

    Google Scholar 

  12. Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) New antibiotics, bleomycin A and B. Antibiot Ser A (Tokyo) 19:200–209

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Crooke, S.T., Strong, J.E., Bradner, W.T., Schurig, J., Schlein, A., Prestayko, A.W. (1981). Tallysomycin, A Third Generation Bleomycin Analog. In: Carter, S.K., Sakurai, Y., Umezawa, H. (eds) New Drugs in Cancer Chemotherapy. Recent Results in Cancer Research, vol 76. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81565-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81565-2_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81567-6

  • Online ISBN: 978-3-642-81565-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics